Viread and Seborrhoeic dermatitis - a phase IV clinical study of FDA data

Summary:

Seborrhoeic dermatitis is reported as a side effect among people who take Viread (tenofovir disoproxil fumarate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Lamivudine, and have Portal hypertension.

The phase IV clinical study analyzes which people have Seborrhoeic dermatitis when taking Viread. It is created by eHealthMe based on reports of 51,434 people who have side effects when taking Viread from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Seborrhoeic dermatitis?

Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp) is found to be associated with 362 drugs and 513 conditions by eHealthMe. Check the latest studies of Seborrhoeic dermatitis.

On Aug, 02, 2026

51,434 people reported to have side effects when taking Viread.
Among them, 12 people (0.02%) have Seborrhoeic dermatitis.

Could Viread cause Seborrhoeic dermatitis?

Among these 12 people:

How long have people been on Viread when they have Seborrhoeic dermatitis? *

What is the gender of people who have Seborrhoeic dermatitis when taking Viread? *

female: 0.0 %
male: 100 %

What is the age of people who have Seborrhoeic dermatitis when taking Viread? *

What are other drugs people take besides Viread? *

What are other side effects people have besides Seborrhoeic dermatitis? *

Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 7 people, 58.33%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 7 people, 58.33%
Arrhythmias (irregular heartbeat): 7 people, 58.33%
Laryngeal Erythema (redness of larynx): 6 people, 50.00%
Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx): 5 people, 41.67%
Laryngeal Oedema (swelling of larynx): 5 people, 41.67%
Itching: 5 people, 41.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 25.00%
Toxic Skin Eruption (skin breakdown due to toxic substance): 3 people, 25.00%
Faecal Incontinence (a lack of control over passing stool): 3 people, 25.00%

What are the existing conditions these people have? *

Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 7 people, 58.33%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and have Seborrhoeic dermatitis?

- Check whether Seborrhoeic dermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viread:

Viread (51,542 reports)

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (362 drugs)

Browse all the conditions that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (513 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate (the active ingredients of Viread) and Viread (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.